Surgery Partners (SGRY) Cost of Revenue (2016 - 2025)
Surgery Partners (SGRY) has disclosed Cost of Revenue for 12 consecutive years, with -$438.3 million as the latest value for Q4 2025.
- Quarterly Cost of Revenue fell 12.91% to -$438.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $201.4 million through Dec 2025, up 290.36% year-over-year, with the annual reading at $201.4 million for FY2025, 0.15% changed from the prior year.
- Cost of Revenue hit -$438.3 million in Q4 2025 for Surgery Partners, down from $208.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $215.8 million in Q1 2025 to a low of -$438.3 million in Q4 2025.
- Historically, Cost of Revenue has averaged $75.4 million across 5 years, with a median of $172.4 million in 2022.
- Biggest five-year swings in Cost of Revenue: skyrocketed 448.29% in 2021 and later plummeted 310.85% in 2022.
- Year by year, Cost of Revenue stood at $171.5 million in 2021, then tumbled by 310.85% to -$361.6 million in 2022, then soared by 153.98% to $195.2 million in 2023, then tumbled by 298.87% to -$388.2 million in 2024, then dropped by 12.91% to -$438.3 million in 2025.
- Business Quant data shows Cost of Revenue for SGRY at -$438.3 million in Q4 2025, $208.9 million in Q3 2025, and $215.0 million in Q2 2025.